Is Assertio Holdings Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Assertio Holdings Inc (ASRT) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Assertio Holdings Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Assertio Holdings Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Assertio Holdings Inc?

Muslim investors may consider investing in Assertio Holdings Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Assertio Holdings Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Assertio Holdings Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Assertio Holdings Inc updated?

The Shariah compliance status of Assertio Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Assertio Holdings Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Assertio Holdings Inc?

You can check the latest Shariah compliance status of Assertio Holdings Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ASRT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 18, 2026

Report Source: 2025 Annual Report

Assertio Holdings Inc. Stock Analysis ASRT

United States Health Care Micro Cap Report: 2025 Annual

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 53 full-time employees. The firm has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.

Key Statistics of Assertio Holdings Inc (ASRT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$23.31$23.35

Today's Open

$23.31

Volume

275.38K

P/E Ratio (TTM)

52 Week Range

$8.61$23.36

Market Cap

142.82M

Avg. Volume

455.91K

Dividend Yield

Financial Metrics & Statements of Assertio Holdings Inc (ASRT)

FAQ's for Assertio Holdings Inc (ASRT)

According to Musaffa’s Shariah screening methodology, Assertio Holdings Inc (ASRT) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.